CNS Neuroscience & Therapeutics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2024-02-27 ms5000001076623088 来自重庆

偏重的研究方向：神经;神经疾病
经验分享：请问大家二审需要多久时间呀？

109 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2025-04-25 ms1000000096818640 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：神经科学;毒理
经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验

10 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2023-10-10 ms9000001673281029 来自云南省

Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？

0 11 举报

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2023-06-18 ms4000000772428461 来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：神经疾病
经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛

86 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2023-10-25 ms2000000313066012 来自陕西省

10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。

64 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2024-09-12 ms6000002090135599 来自浙江省

投稿命中率:5.0
偏重的研究方向：神经病学;临床
经验分享：9.11 submitted
9.12 Under Review

65 13 举报

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2025-02-20 ms6000000967348712 来自艾伯塔

投稿命中率:50.0
偏重的研究方向：精神病学
经验分享：4天秒拒，太惨了，想知道什么原因。
We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics.

Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts.

34 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2024-01-29 305549419 来自重庆

审稿速度:3.0 | 投稿命中率:50.0
经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知

101 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2024-08-16 爱臭美的小女孩来自北京

请问各位战友，需要WB未裁剪膜吗

120 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2189755, encodeId=e0362189e5575, content=偏重的研究方向：神经;神经疾病 经验分享：请问大家二审需要多久时间呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a35537291, createdName=ms5000001076623088, createdTime=Tue Feb 27 21:36:59 CST 2024, time=2024-02-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2262216, encodeId=cff9226221659, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经科学;毒理 经验分享：已接受一篇，编辑决定权很大，送审以后接受率高，我的第一篇没送审，第二篇送审后接受投稿到第一次修回1月余修回补实验2个月小修到接受半个月接收到proof一周需要提供WB全膜统计数据需要正太检验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75185410389, createdName=ms1000000096818640, createdTime=Fri Apr 25 11:33:15 CST 2025, time=2025-04-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2161923, encodeId=6892216192378, content=Under Review 一个月了，有没有同样状态的小伙伴，这个杂志就是这么慢吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Tue Oct 10 10:54:38 CST 2023, time=2023-10-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2143463, encodeId=5cec214346331, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：神经疾病 经验分享：一提交就under review，审稿20天后有一个审稿人的小修意见，想问下你们的审稿人有多少个呀，为啥我只有一个，后面还会再邀请审稿人嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9445716232, createdName=ms4000000772428461, createdTime=Sun Jun 18 09:27:26 CST 2023, time=2023-06-18, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164931, encodeId=49a5216493126, content=10月14号投的稿，旧系统一直是Awaiting Reviewer Selection状态，这个是还在编辑那还是决定送审等审稿人同意审稿。有没有投过的朋友了解的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01fd5683673, createdName=ms2000000313066012, createdTime=Wed Oct 25 21:46:24 CST 2023, time=2023-10-25, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2225374, encodeId=052822253e4fe, content=投稿命中率:5.0 偏重的研究方向：神经病学;临床 经验分享：9.11 submitted 9.12 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96c69031712, createdName=ms6000002090135599, createdTime=Thu Sep 12 13:14:14 CST 2024, time=2024-09-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252765, encodeId=ca2f2252e65b5, content=投稿命中率:50.0 偏重的研究方向：精神病学 经验分享：4天秒拒，太惨了，想知道什么原因。 We have made the decision not to publish your manuscript in CNS Neuroscience & Therapeutics. Thank you for considering CNS Neuroscience & Therapeutics for the publication of your research. I hope the outcome of this specific submission will not discourage you from submitting future manuscripts., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77119260759, createdName=ms6000000967348712, createdTime=Thu Feb 20 10:44:49 CST 2025, time=2025-02-20, status=1, ipAttribution=艾伯塔), GetPortalCommentsPageByObjectIdResponse(id=2184632, encodeId=706f218463273, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：请问从接收到出版需要多长时间呢，接收半个多月了也没收到交版面费的通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa2e4338849, createdName=305549419, createdTime=Mon Jan 29 13:19:24 CST 2024, time=2024-01-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2220398, encodeId=a13722203989b, content=请问各位战友，需要WB未裁剪膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff4d5246870, createdName=爱臭美的小女孩, createdTime=Fri Aug 16 08:12:44 CST 2024, time=2024-08-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1082803, encodeId=ad701082803dd, content=请问需要提供原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200707/da89718c4a034f1e8a2f6a8d08760ea6/bd05f81110a54f0581e4b59eb064d918.jpg, createdBy=90952484483, createdName=叶子🍃❤️nature🐶, createdTime=Tue Dec 21 23:25:58 CST 2021, time=2021-12-21, status=1, ipAttribution=)]

2021-12-21 叶子🍃❤️nature🐶

请问需要提供原始数据吗？

132 6 举报

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务